Speaker: Dr.PARMINDER SINGH
Chairperson: Dr.B.L.BHARDWAJ
APPROACH TO A PATIENT WITH HEADACHE
1
 To learn about the major types of
headaches
 To understand the difference between
primary and secondary headaches
 Be familiar with the ‘RED FLAGS’
 To understand when and how to
investigate headache
2
 Extra-cranial pain
sensitive structures:
◦ Sinuses
◦ Eyes/orbits
◦ Ears
◦ Teeth
◦ TMJ
◦ Blood vessels
 Intra-cranial pain
sensitive structures:
◦ Arteries
◦ Veins
◦ Meninges
◦ Dura
3
 Sensory stimuli from head are conveyed to
CNS via-
 Trigeminal nerves- for structures above the
tentorium in the anterior and middle fossae
of the skull
 C1, C2, C3 – for structures in the posterior
fossa and inferior surface of tentorium
4
 Broadly headaches are divided primarily into
2 main types by Headache classification
committee of International Headache Society:
 PRIMARY HEADACHES - Those in which
headache and its associated features are
disease in themselves
 SECONDARY HEADACHES – Those that are
caused exogenously
5
 The Primary Headaches
 1. Migraine
 2. Tension-type headache
 3. Cluster headache and other trigeminal
autonomic cephalgias
 4.Other primary headaches:-
 a. Primary stabbing headache
 b. Primary cough headache
 c. Primary exertional headache
6
 d. Primary headache associated with
sexual activity – Pre orgasmic
 - Orgasmic
 e.Hypnic headache
 f. Primary thunderclap headache
 g. Hemicrania continua
 h. New daily persistant headache
7
8
 The Secondary Headaches
 Headache attributed to –
 1. Head and/or neck trauma
 2. Cranial or cervical vascular disorder
 3. Non-vascular intracranial disorder
 4. Substance or its withdrawal
 5. Infection
 6. Disorder of homeostasis

9
 7. Disorder of cranium, neck, eyes, ears,
nose, sinuses, teeth, mouth, or other facial or
cranial structures.
 8. Psychiatric disorders
 Cranial neuralgias, central and primary
facial pain and other headaches

10
11
12
 RED FLAGS
 1. Head or neck injury
 2. New onset or new type or worsening
pattern of existing headache
 3. New level of pain(e.g. worst ever)
 4. Abrupt or split-second onset
 5. Triggered by valsalva manouvre/cough
 6. Triggered by exertion
 7. Triggered by sexual activity
 8. Headache during pregnancy/peurperium
13
 9. Age>50 yrs
 10. Neurological signs/symptoms
 11. Systemic illness
 a. Fever
 b. Nuchal rigidity
 c. Weight loss
 d. Scalp artery tenderness
 12. Secondary risk factors
 a. Cancer
 b. Immunocompromised host
 c. Recent travel
14
 YELLOW FLAGS
 1. Wakes patient from sleep at night
 2. New onset side – locked headache
 3. Postural headaches
15
 RED FLAGS
 Head or neck
injury
 CONSIDERATIONS
 Hemorrhage
 Epidural
 Subdural
 Subarachnoid
 Intraparenchymal
 Dissection
 Carotid arteries
 Vertebral arteries
16
 New onset or new
type or worsening
pattern of existing
headache
 New level of pain
(e.g. “worst ever”)
 Mass lesion
 Subdural hematoma
 Medication overuse
 Meningoencephaliti
s
 Subarachnoid
hemorrhage
17
 Abrupt or split-second
onset
 Intraparenchymal
hemorrhage
 Bleed into a mass or AVM
 Dissection
 Cerebral venous thrombosis
 Pituitary apoplexy
 Spontaneous intracranial
hypotension
 Reversible cerebral
vasoconstriction syndrome
 Acute hypertensive crisis
 Mass lesion esp.post fossa
 Primary thunderclap
headache
18
 Triggered by
Valsalva manouver
or cough
 Triggered by
exertion
 Chiari malformation
 Mass lesion
 Subarachnoid
hemorrhage
 Dissection
 Angina equivalent
 Pheochromocytoma
19
 Triggered by sexual
activity( Pre-
orgasmic,orgasmic)
 Headache during
pregnancy or
puerperium
 Subarachnoid
hemorrhage
 Dissection
 Cortical
venous/cranial
sinus thrombosis
 Pituitary apoplexy
20
 Age > 50 yrs
 Neurologicalsigns or
symptoms(seizures,con
fusion,impaired
alertness,weakness,
papilloedema etc.)
 Brain tumour(primary,
metastatic)
 Cerebrovascular
diseases
 Giant cell arteritis
 Mass lesion
 AVM
 CTD
 Benign intracranial
hypertension
 Meningoencephalitis
21
 Systemic illness
 Fever
 Nuchal rigidity
 Weight loss
 Scalp artery
tenderness
 Meningoencephalitis
 Meningeal
carcinomatosis
 Lyme disease
 Collagen vascular
diseases
 Malignancy
 Giant cell arteritis
22
 Secondary risk
factors
 Cancer

Immunocompromis
ed host
 Recent travel
 Metastatic disease
 Opportunistic
infection
 Meningoencephaliti
s
23
 YELLOW FLAGS
 Wakes patient from
sleep at night
 Sleep related
disorders(e.g.
Obstructive sleep
apnea)
 Rebound
withdrawal
headaches
 Poorly controlled
hypertension
24
 New onset side-
locked headaches
 Postural headaches
 Head trauma
 Dissection
 Intracranial aneurysm
 Lung carcinoma
 Spontaneous
intracranial
hypotension
 Post lumbar puncture
headache
25
 Affects 15% of the general population
 Female > Males
 Family History present in 70%
 Pathophysiology: vascular vs neurologic
 Precipitants: caffeine, chocolate, alcohol,
cheese, BCP/HRT, menses, stress
26
 Diagnostic criteria:
1. 5 attacks in 6 months
2. Headaches lasting 4-72 h with >/= 2:
- unilateral
- pulsatile
- moderate to severe in intensity
- aggravated by activity
3. Associated with >/= 1:
- nausea/vomiting
- photophobia/phonophobia
27
 Subtypes:
◦ Auras – visual or sensory
◦ Scintillating scotoma
◦ Fortification spectra
◦ Ophthalmoplegic
◦ CN III palsy
◦ Vertbrobasilar
◦ hemiplegic
28
Scintillating Scotomas
Progression of a typical aura
over 30 minutes
BMJ 2002; 325:881-6 29
 Mild attacks: NSAIDS +/- dopamine
antagonists
◦ eg. ASA 650-1300 mg q4h + metoclopromide 10
mg PO/IV
 Moderate attacks:
◦ NSAIDS (ibuprofen 400-800 mg PO q2-6h)
◦ 5-HT1 receptor agonists
 Selective – sumatriptan 50-100 mg PO
 Nonselective – ergot 1-2 mg PO q1h x 3
CMAJ 1997; 156: 1273-87 30
 Severe & Ultra-severe attacks:
◦ First line:
 DHE 0.5-1 mg q1h IM/SC/IV
 sumatriptan 50-100 mg PO or 6 mg SC
◦ Second line:
 chlorpromazine 50 mg IM
 Prochlorperazine 5-10 mg IV/IM
 dexamethasone 12-20 mg IV
CMAJ 1997; 156: 1273-87 31
 Consider if >/3 attacks/month, impaired
quality of life:
◦ B-blockers
◦ Calcium channel blockers
◦ TCA (amitriptyline)
◦ NSAIDS
◦ Valproic acid
◦ 5HT2 Antagonists (methysergide, pizotyline)
CMAJ 1997; 156: 1273-87
32
 Most common type, typically brought on by
stress, lasting 30 min to 7 d
 Diagnostic Criteria >/= 2:
◦ Pressing/tightening, non-pulsating
◦ Mild-moderate
◦ Bilateral
◦ Not worsened by ADLs
◦ Photo or phonophobia (not coincident)
◦ Not associated with N/V
 Treatment: reassurance, NSAIDS
33
 Diagnostic criteria:-
 A. At least 5 attacks fulfilling B-D;
 B. Severe or very severe unilateral orbital, supraorbital,
and/or temporal pain lasting 15-180 min if untreated;
 C. Headache is accompanied by at least 1 of the following:
 1. I/L conj. Injection/lacrimation
 2. I/L nasal congestion/rhinorrhoea
 3. I/L forehaed and facial swelling
 4. I/L eyelid edema
 5. I/L miosis and/or ptosis
 6. A sense of restlessness/agitation
 D. Attacks have frequency from 1 every other day to 8/day
34
35
36
37
PRIMARY STABBING HEADACHE
 Pain confined to head, rarely facial.
 Stabbing pain lasting 1 to many sec and occuring as a single stab
or series of stabs
 Recurring at intervals of hours to days
 PRIMARY COUGH HEADACHE
 B/L headache of sudden onset, lasting minutes, precipitated by
coughing
 Prevented by avoiding coughing
 Diagnosed only after structural lesions, such as posterior fossa
tumour, have been excluded by neuroimaging
38
 HYPNIC HEADACHE
 Headache of moderate to severe nature that
typically occur few hrs after going to sleep
 Last from 15–30 mins
 Typically generalised although may be
unilateral and can be throbbing
 Falling back to sleep only to be awoken by
further attack few hrs later with upto 3
repetitions of this pattern over night
39
THUNDERCLAP HEADACHES
40
 PRIMARY THUNDERCLAP
HEADACHE(TCH)
 Defined as severe headache reaching maximal
intensity within seconds to a minute
 Thunderclap headache is a NEUROLOGICAL
EMERGENCY
 Numerous etiologies ranging from benign to
life-threatening have been reported most
notable being aneurysmal subarachnoid
hemorrhage
41
 DISORDERS A/W TCH:-
 1. Subarachnoid hemorrhage
 2. Unruptured intracranial aneurysm(“Sentinal
Headache”)
 3. Cervical artery dissection
 4. Stroke( H’ragic>Ischemic)
 5. Cerebral venous sinus thrombosis
42
 6. Intraparenchymal hemorrhage
 7. Spontaneous intracranial hypotension
 8. Reversible cerebral vasoconstrictn synd.
 9. Reversible post. Leukoencephalopathy
 10. Infections- intracranial,sinusitis
 11. Primary TCH
43
 REVERSIBLE CEREBRAL VASOCONSTRICTION
SYNDROME:-
 Diagnostic criteria-
 1. TCH with/without other neurological signs/symptoms
 2. No evidence for aneurysmal SAH
 3. Normal/near normal CSF
 4. Angiographic documentation of multifocal segmental
cerebral artery vasoconstriction
 5. Reversal of vasoconstriction within 12 wks of onset
44
 RCVS includes-
 1. Call-Fleming syndrome
 2. Benign angiopathy of CNS
 3. CNS pseudovasculitis
 4. Isolated benign cerebral vasculitis
 5. Benign acute cerebral vasculopathy
45
 6. Drug induced cerebral
vasculopathy(cannabis,sympathomimetic,serotonergi
c agents)
 7. Postpartum angiopathy
 8.Acute hypertension(Pheochromocytoma)
 9.Reversible Posterior Leukoencephalopathy
 10. Bath headache
 11. Orgasmic headache
46
 CVS- CCBs
 Antiarrhythmics
 α1 adrenergic antagonists
 α2 adrenergic agonists
 β adrenergic antagonists
 ACE inhibitors
 Angiotensin II inhibitors
 Nitrates
 Diuretics
 Phosphodiesterase inhibitors
 Antimicrobials
 Immunologic/antiinflammatory
47
 Gastrointestinal- H2 blockers/ PPIs
 5HT3 antagonists
 Endocrinological- Gonadotropin inhibitors
 Dopamine receptor agonists
 Psychiatric- Antidepressants/antipsychotics
 Sedative/hypnotics
 Misc- Antiobesity
 Statins
 Retinoids
 Prostaglandins
 Agents for erectile dysfunction
48
 Primary
 >4hrs daily-
 1. Chr. Migraine
 2. Chr. Tension
headache
 3. Hemicrania continua
 4. New daily persistant
headache
 Secondary
 1. Post traumatic
 2. Inflammatory
 3. Chr CNS infection
 4. Substance abuse
headache
49
 <4 hrs
 1. Chr. Cluster
headacahe
 2. Chr. paroxysmal
hemicrania
 3. SUNCT
 4. Hypnic headaache
50
 Primary
 1.Migranious type
 2.Featureless(tension-
type)
 Secondary
 1. SAH
 2. Low CSF volume
headache
 3. Raised CSF volume
headache
 4. Post traumatic
 5. Chr. Meningitis
51
 1. Imaging studies:
 CT and MRI
 Plain X-ray films
 Cerebral angiography- MRA and CTA
 Myelography and radioisotope cisternography
 2. CSF examination
 3. Electrophysiological testing
 4. General medical tests
52
 MRI preferred:-
 1. Vascular disease- Cerebral/venous
infarction
 2. Neoplastic disease
 a. Brain tumors esp. in POST. FOSSA
 b. Skull base tumors
 c. Meningeal carcinomatosis
 d. Pituitary tumors
53
 3. Infections- Cerebritis/abscess/meningitis
/encephalitis
 4. Others- Chiari malformation
 CSF hypotension
 Foramen magnum/upper Cx
spine lesions
 Pituitary apoplexy
 CADASIL,MELAS,SMART
54
 CT preferred:-
 1. Fractures (calvarium)
 2. Acute hemorrhage (SAH,intracerebral)
 3. Paranasal sinus and mastoid air cells Diseases
 Draw b/w MRI/CT:-
 MR/CT angiography- Vasculitis
 Intracranial aneurysm
 Dissections
 MR/CT venography- Cerebral venous thrombosis
55
 CT
 - Increased lifetime risk of cancer
 - Anaphylaxis and renal insufficiency
 MRI
 - Increased detection of incidental
findings
 - Nephrogenic systemic fibrosis
56
 Cerebral angiography
 - Access site hematoma (4.2%)
 - Strokes(0.14%)
 - Deaths(0.06%)
 LP
 - Post-LP headaches
 - Persistent CSF leaks
 - Bleeding
 - Low back pain
 - Infection

57
 It is important to differentiate between Primary
and Secondary Headaches
 “HISTORY” is the most important diagnostic tool
in evaluation of headache
 Early recognition of RED FLAGS in a case of
headache is invaluable
 Not all cases of headache require neuroimaging,
judicious use of investigations must be done
weighing their benefits and harms…
58
59

Approach to a_case_of_headache

  • 1.
    Speaker: Dr.PARMINDER SINGH Chairperson:Dr.B.L.BHARDWAJ APPROACH TO A PATIENT WITH HEADACHE 1
  • 2.
     To learnabout the major types of headaches  To understand the difference between primary and secondary headaches  Be familiar with the ‘RED FLAGS’  To understand when and how to investigate headache 2
  • 3.
     Extra-cranial pain sensitivestructures: ◦ Sinuses ◦ Eyes/orbits ◦ Ears ◦ Teeth ◦ TMJ ◦ Blood vessels  Intra-cranial pain sensitive structures: ◦ Arteries ◦ Veins ◦ Meninges ◦ Dura 3
  • 4.
     Sensory stimulifrom head are conveyed to CNS via-  Trigeminal nerves- for structures above the tentorium in the anterior and middle fossae of the skull  C1, C2, C3 – for structures in the posterior fossa and inferior surface of tentorium 4
  • 5.
     Broadly headachesare divided primarily into 2 main types by Headache classification committee of International Headache Society:  PRIMARY HEADACHES - Those in which headache and its associated features are disease in themselves  SECONDARY HEADACHES – Those that are caused exogenously 5
  • 6.
     The PrimaryHeadaches  1. Migraine  2. Tension-type headache  3. Cluster headache and other trigeminal autonomic cephalgias  4.Other primary headaches:-  a. Primary stabbing headache  b. Primary cough headache  c. Primary exertional headache 6
  • 7.
     d. Primaryheadache associated with sexual activity – Pre orgasmic  - Orgasmic  e.Hypnic headache  f. Primary thunderclap headache  g. Hemicrania continua  h. New daily persistant headache 7
  • 8.
  • 9.
     The SecondaryHeadaches  Headache attributed to –  1. Head and/or neck trauma  2. Cranial or cervical vascular disorder  3. Non-vascular intracranial disorder  4. Substance or its withdrawal  5. Infection  6. Disorder of homeostasis  9
  • 10.
     7. Disorderof cranium, neck, eyes, ears, nose, sinuses, teeth, mouth, or other facial or cranial structures.  8. Psychiatric disorders  Cranial neuralgias, central and primary facial pain and other headaches  10
  • 11.
  • 12.
  • 13.
     RED FLAGS 1. Head or neck injury  2. New onset or new type or worsening pattern of existing headache  3. New level of pain(e.g. worst ever)  4. Abrupt or split-second onset  5. Triggered by valsalva manouvre/cough  6. Triggered by exertion  7. Triggered by sexual activity  8. Headache during pregnancy/peurperium 13
  • 14.
     9. Age>50yrs  10. Neurological signs/symptoms  11. Systemic illness  a. Fever  b. Nuchal rigidity  c. Weight loss  d. Scalp artery tenderness  12. Secondary risk factors  a. Cancer  b. Immunocompromised host  c. Recent travel 14
  • 15.
     YELLOW FLAGS 1. Wakes patient from sleep at night  2. New onset side – locked headache  3. Postural headaches 15
  • 16.
     RED FLAGS Head or neck injury  CONSIDERATIONS  Hemorrhage  Epidural  Subdural  Subarachnoid  Intraparenchymal  Dissection  Carotid arteries  Vertebral arteries 16
  • 17.
     New onsetor new type or worsening pattern of existing headache  New level of pain (e.g. “worst ever”)  Mass lesion  Subdural hematoma  Medication overuse  Meningoencephaliti s  Subarachnoid hemorrhage 17
  • 18.
     Abrupt orsplit-second onset  Intraparenchymal hemorrhage  Bleed into a mass or AVM  Dissection  Cerebral venous thrombosis  Pituitary apoplexy  Spontaneous intracranial hypotension  Reversible cerebral vasoconstriction syndrome  Acute hypertensive crisis  Mass lesion esp.post fossa  Primary thunderclap headache 18
  • 19.
     Triggered by Valsalvamanouver or cough  Triggered by exertion  Chiari malformation  Mass lesion  Subarachnoid hemorrhage  Dissection  Angina equivalent  Pheochromocytoma 19
  • 20.
     Triggered bysexual activity( Pre- orgasmic,orgasmic)  Headache during pregnancy or puerperium  Subarachnoid hemorrhage  Dissection  Cortical venous/cranial sinus thrombosis  Pituitary apoplexy 20
  • 21.
     Age >50 yrs  Neurologicalsigns or symptoms(seizures,con fusion,impaired alertness,weakness, papilloedema etc.)  Brain tumour(primary, metastatic)  Cerebrovascular diseases  Giant cell arteritis  Mass lesion  AVM  CTD  Benign intracranial hypertension  Meningoencephalitis 21
  • 22.
     Systemic illness Fever  Nuchal rigidity  Weight loss  Scalp artery tenderness  Meningoencephalitis  Meningeal carcinomatosis  Lyme disease  Collagen vascular diseases  Malignancy  Giant cell arteritis 22
  • 23.
     Secondary risk factors Cancer  Immunocompromis ed host  Recent travel  Metastatic disease  Opportunistic infection  Meningoencephaliti s 23
  • 24.
     YELLOW FLAGS Wakes patient from sleep at night  Sleep related disorders(e.g. Obstructive sleep apnea)  Rebound withdrawal headaches  Poorly controlled hypertension 24
  • 25.
     New onsetside- locked headaches  Postural headaches  Head trauma  Dissection  Intracranial aneurysm  Lung carcinoma  Spontaneous intracranial hypotension  Post lumbar puncture headache 25
  • 26.
     Affects 15%of the general population  Female > Males  Family History present in 70%  Pathophysiology: vascular vs neurologic  Precipitants: caffeine, chocolate, alcohol, cheese, BCP/HRT, menses, stress 26
  • 27.
     Diagnostic criteria: 1.5 attacks in 6 months 2. Headaches lasting 4-72 h with >/= 2: - unilateral - pulsatile - moderate to severe in intensity - aggravated by activity 3. Associated with >/= 1: - nausea/vomiting - photophobia/phonophobia 27
  • 28.
     Subtypes: ◦ Auras– visual or sensory ◦ Scintillating scotoma ◦ Fortification spectra ◦ Ophthalmoplegic ◦ CN III palsy ◦ Vertbrobasilar ◦ hemiplegic 28
  • 29.
    Scintillating Scotomas Progression ofa typical aura over 30 minutes BMJ 2002; 325:881-6 29
  • 30.
     Mild attacks:NSAIDS +/- dopamine antagonists ◦ eg. ASA 650-1300 mg q4h + metoclopromide 10 mg PO/IV  Moderate attacks: ◦ NSAIDS (ibuprofen 400-800 mg PO q2-6h) ◦ 5-HT1 receptor agonists  Selective – sumatriptan 50-100 mg PO  Nonselective – ergot 1-2 mg PO q1h x 3 CMAJ 1997; 156: 1273-87 30
  • 31.
     Severe &Ultra-severe attacks: ◦ First line:  DHE 0.5-1 mg q1h IM/SC/IV  sumatriptan 50-100 mg PO or 6 mg SC ◦ Second line:  chlorpromazine 50 mg IM  Prochlorperazine 5-10 mg IV/IM  dexamethasone 12-20 mg IV CMAJ 1997; 156: 1273-87 31
  • 32.
     Consider if>/3 attacks/month, impaired quality of life: ◦ B-blockers ◦ Calcium channel blockers ◦ TCA (amitriptyline) ◦ NSAIDS ◦ Valproic acid ◦ 5HT2 Antagonists (methysergide, pizotyline) CMAJ 1997; 156: 1273-87 32
  • 33.
     Most commontype, typically brought on by stress, lasting 30 min to 7 d  Diagnostic Criteria >/= 2: ◦ Pressing/tightening, non-pulsating ◦ Mild-moderate ◦ Bilateral ◦ Not worsened by ADLs ◦ Photo or phonophobia (not coincident) ◦ Not associated with N/V  Treatment: reassurance, NSAIDS 33
  • 34.
     Diagnostic criteria:- A. At least 5 attacks fulfilling B-D;  B. Severe or very severe unilateral orbital, supraorbital, and/or temporal pain lasting 15-180 min if untreated;  C. Headache is accompanied by at least 1 of the following:  1. I/L conj. Injection/lacrimation  2. I/L nasal congestion/rhinorrhoea  3. I/L forehaed and facial swelling  4. I/L eyelid edema  5. I/L miosis and/or ptosis  6. A sense of restlessness/agitation  D. Attacks have frequency from 1 every other day to 8/day 34
  • 35.
  • 36.
  • 37.
  • 38.
    PRIMARY STABBING HEADACHE Pain confined to head, rarely facial.  Stabbing pain lasting 1 to many sec and occuring as a single stab or series of stabs  Recurring at intervals of hours to days  PRIMARY COUGH HEADACHE  B/L headache of sudden onset, lasting minutes, precipitated by coughing  Prevented by avoiding coughing  Diagnosed only after structural lesions, such as posterior fossa tumour, have been excluded by neuroimaging 38
  • 39.
     HYPNIC HEADACHE Headache of moderate to severe nature that typically occur few hrs after going to sleep  Last from 15–30 mins  Typically generalised although may be unilateral and can be throbbing  Falling back to sleep only to be awoken by further attack few hrs later with upto 3 repetitions of this pattern over night 39
  • 40.
  • 41.
     PRIMARY THUNDERCLAP HEADACHE(TCH) Defined as severe headache reaching maximal intensity within seconds to a minute  Thunderclap headache is a NEUROLOGICAL EMERGENCY  Numerous etiologies ranging from benign to life-threatening have been reported most notable being aneurysmal subarachnoid hemorrhage 41
  • 42.
     DISORDERS A/WTCH:-  1. Subarachnoid hemorrhage  2. Unruptured intracranial aneurysm(“Sentinal Headache”)  3. Cervical artery dissection  4. Stroke( H’ragic>Ischemic)  5. Cerebral venous sinus thrombosis 42
  • 43.
     6. Intraparenchymalhemorrhage  7. Spontaneous intracranial hypotension  8. Reversible cerebral vasoconstrictn synd.  9. Reversible post. Leukoencephalopathy  10. Infections- intracranial,sinusitis  11. Primary TCH 43
  • 44.
     REVERSIBLE CEREBRALVASOCONSTRICTION SYNDROME:-  Diagnostic criteria-  1. TCH with/without other neurological signs/symptoms  2. No evidence for aneurysmal SAH  3. Normal/near normal CSF  4. Angiographic documentation of multifocal segmental cerebral artery vasoconstriction  5. Reversal of vasoconstriction within 12 wks of onset 44
  • 45.
     RCVS includes- 1. Call-Fleming syndrome  2. Benign angiopathy of CNS  3. CNS pseudovasculitis  4. Isolated benign cerebral vasculitis  5. Benign acute cerebral vasculopathy 45
  • 46.
     6. Druginduced cerebral vasculopathy(cannabis,sympathomimetic,serotonergi c agents)  7. Postpartum angiopathy  8.Acute hypertension(Pheochromocytoma)  9.Reversible Posterior Leukoencephalopathy  10. Bath headache  11. Orgasmic headache 46
  • 47.
     CVS- CCBs Antiarrhythmics  α1 adrenergic antagonists  α2 adrenergic agonists  β adrenergic antagonists  ACE inhibitors  Angiotensin II inhibitors  Nitrates  Diuretics  Phosphodiesterase inhibitors  Antimicrobials  Immunologic/antiinflammatory 47
  • 48.
     Gastrointestinal- H2blockers/ PPIs  5HT3 antagonists  Endocrinological- Gonadotropin inhibitors  Dopamine receptor agonists  Psychiatric- Antidepressants/antipsychotics  Sedative/hypnotics  Misc- Antiobesity  Statins  Retinoids  Prostaglandins  Agents for erectile dysfunction 48
  • 49.
     Primary  >4hrsdaily-  1. Chr. Migraine  2. Chr. Tension headache  3. Hemicrania continua  4. New daily persistant headache  Secondary  1. Post traumatic  2. Inflammatory  3. Chr CNS infection  4. Substance abuse headache 49
  • 50.
     <4 hrs 1. Chr. Cluster headacahe  2. Chr. paroxysmal hemicrania  3. SUNCT  4. Hypnic headaache 50
  • 51.
     Primary  1.Migranioustype  2.Featureless(tension- type)  Secondary  1. SAH  2. Low CSF volume headache  3. Raised CSF volume headache  4. Post traumatic  5. Chr. Meningitis 51
  • 52.
     1. Imagingstudies:  CT and MRI  Plain X-ray films  Cerebral angiography- MRA and CTA  Myelography and radioisotope cisternography  2. CSF examination  3. Electrophysiological testing  4. General medical tests 52
  • 53.
     MRI preferred:- 1. Vascular disease- Cerebral/venous infarction  2. Neoplastic disease  a. Brain tumors esp. in POST. FOSSA  b. Skull base tumors  c. Meningeal carcinomatosis  d. Pituitary tumors 53
  • 54.
     3. Infections-Cerebritis/abscess/meningitis /encephalitis  4. Others- Chiari malformation  CSF hypotension  Foramen magnum/upper Cx spine lesions  Pituitary apoplexy  CADASIL,MELAS,SMART 54
  • 55.
     CT preferred:- 1. Fractures (calvarium)  2. Acute hemorrhage (SAH,intracerebral)  3. Paranasal sinus and mastoid air cells Diseases  Draw b/w MRI/CT:-  MR/CT angiography- Vasculitis  Intracranial aneurysm  Dissections  MR/CT venography- Cerebral venous thrombosis 55
  • 56.
     CT  -Increased lifetime risk of cancer  - Anaphylaxis and renal insufficiency  MRI  - Increased detection of incidental findings  - Nephrogenic systemic fibrosis 56
  • 57.
     Cerebral angiography - Access site hematoma (4.2%)  - Strokes(0.14%)  - Deaths(0.06%)  LP  - Post-LP headaches  - Persistent CSF leaks  - Bleeding  - Low back pain  - Infection  57
  • 58.
     It isimportant to differentiate between Primary and Secondary Headaches  “HISTORY” is the most important diagnostic tool in evaluation of headache  Early recognition of RED FLAGS in a case of headache is invaluable  Not all cases of headache require neuroimaging, judicious use of investigations must be done weighing their benefits and harms… 58
  • 59.